- Home
- ATOS vs MAMO Comparison
ATOS vs MAMO Comparison
Compare ATOS & MAMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- MAMO
- Stock Information
- Founded
- ATOS 2009
- MAMO 2008
- Country
- ATOS United States
- MAMO United States
- Employees
- ATOS N/A
- MAMO N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- MAMO
- Sector
- ATOS Health Care
- MAMO
- Exchange
- ATOS Nasdaq
- MAMO NYSE
- Market Cap
- ATOS 112.5M
- MAMO 91.0M
- IPO Year
- ATOS 2012
- MAMO 2024
- Fundamental
- Price
- ATOS $0.86
- MAMO $2.10
- Analyst Decision
- ATOS Strong Buy
- MAMO
- Analyst Count
- ATOS 4
- MAMO 0
- Target Price
- ATOS $6.17
- MAMO N/A
- AVG Volume (30 Days)
- ATOS 668.8K
- MAMO 4.7K
- Earning Date
- ATOS 05-13-2025
- MAMO 08-11-2025
- Dividend Yield
- ATOS N/A
- MAMO N/A
- EPS Growth
- ATOS N/A
- MAMO N/A
- EPS
- ATOS N/A
- MAMO N/A
- Revenue
- ATOS N/A
- MAMO $95,959,187.00
- Revenue This Year
- ATOS N/A
- MAMO N/A
- Revenue Next Year
- ATOS N/A
- MAMO N/A
- P/E Ratio
- ATOS N/A
- MAMO N/A
- Revenue Growth
- ATOS N/A
- MAMO N/A
- 52 Week Low
- ATOS $0.55
- MAMO $1.85
- 52 Week High
- ATOS $1.66
- MAMO $4.66
- Technical
- Relative Strength Index (RSI)
- ATOS 51.39
- MAMO N/A
- Support Level
- ATOS $0.84
- MAMO N/A
- Resistance Level
- ATOS $0.93
- MAMO N/A
- Average True Range (ATR)
- ATOS 0.06
- MAMO 0.00
- MACD
- ATOS -0.00
- MAMO 0.00
- Stochastic Oscillator
- ATOS 66.40
- MAMO 0.00
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About MAMO MASSIMO GROUP
Massimo Group is engaged in the mid-tier band the (Mid-Tier Band) of the Powersports Vehicles and Boats Industry. It manufacture, import and distribute a diversified portfolio of products divided into two main lines: a motor sports brand consisting of utility terrain vehicles (UTVs), all-terrain vehicles (ATVs), motorcycles, scooters, golf carts, and a juvenile line from go karts to balance bikes; and a motor boat line consisting of pontoon and tritoon boats (Pontoon Boats).